M&A
Medical equipment
We advised
OxigenAr and Pulmonair merged with Vivisol into a single operation.
May 2026
Results
Over R$ 400 million in advised strategic transactions, plus what Grupo Evolua has delivered in tax, corporate and succession. The market never heard about most of it.
- Advised strategic transactions
- R$ 400 M +
- Companies served by the group
- 450 +
- Partners’ track record
- 20 yrs +
Transactions
The announcements the parties authorized us to publish, advised by Evolua Capital.
M&A
Service | Health
We advised
Estância Maringá (PR) foi adquirida pela VIV Saúde.
Jan 2026
M&A
Service | Health
We advised
Estância Resiliência (DF) foi adquirida pela VIV Saúde.
Jul 2025
M&A
Tech
We advised
MyPharma was sold in full to Grupo SC.
Jan 2023
M&A
Testing laboratory
We advised
Elementum Laboratório de Controle de Qualidade was sold in full.
Jan 2023
M&A
Technology
We advised
Intelltech sold part of its shares in a strategic transaction.
Jul 2021
Part of our advised deals is not disclosed, under confidentiality agreements.